Citations

Institution: Mayo Clinic Clear

Showing 10 of 108119 citations.

Commentary
Lieske, John C.

Clinical Chemistry | May 29, 2013 | Volume: 59 | Issue: 6 | Pages: 890-890

10.1373/clinchem.2012.199307 | PMID 23719824 Get It

Physicians and Patient Spirituality
Graner, John L.

Annals of Internal Medicine | May 29, 2013 | Volume: 137 | Issue: 5_Part_1 | Pages: 372

10.7326/0003-4819-137-5_part_1-200209030-00029 Get It

Videotape-Based Decision Aid for Colon Cancer Screening
Harewood, Gavin C.

Annals of Internal Medicine | May 29, 2013 | Volume: 135 | Issue: 8_Part_1 | Pages: 634

10.7326/0003-4819-135-8_part_1-200110160-00016 | PMID 11601937 Get It

Calcium Regulation and Bone Mineral Metabolism in Elderly Patients with Chronic Kidney Disease
Tejwani, Vickram, Qian, Qi , Tejwani, Vickram

Nutrients | May 29, 2013 | Volume: 5 | Issue: 6 | Pages: 1913-1936

10.3390/nu5061913 | PMID 23760058 Get It

The elderly chronic kidney disease (CKD) population is growing. Both aging and CKD can disrupt calcium (Ca2+) homeostasis and cause alterations of multiple Ca2+-regulatory mechanisms, including parathyroid hormone, vitamin D, fibroblast growth factor-23/Klotho, calcium-sensing receptor and Ca2+-phosphate product. These alterations can be deleterious to bone mineral metabolism and soft tissue health, leading to metabolic bone disease and vascular calcification and aging, termed CKD-mineral and bone disorder (MBD). CKD-MBD is associated with morbid clinical outcomes, including fracture, cardiovascular events and all-cause mortality. In this paper, we comprehensively review Ca2+ regulation and bone mineral metabolism, with a special emphasis on elderly CKD patients. We also present the current treatment-guidelines and management options for CKD-MBD.
What Can We Learn From Regional Vulnerability to amyloid-β Accumulation in Nondemented individuals?
Shinohara, Mitsuru , Bu, Guojun

Neurodegenerative Disease Management | May 29, 2013 | Volume: 3 | Issue: 3 | Pages: 187-189

10.2217/nmt.13.20 Get It

Ulnar nerve innervation of the medial head of the triceps brachii muscle: A cadaveric study
Loukas, Marios , Bellary, Sharath, Yüzbaşıoğlu, Neslihan , Tubbs, R. Shane , Spinner, Robert J. , Shoja, Mohammadali M.

Clinical Anatomy | May 29, 2013 | Volume: 26 | Issue: 8 | Pages: 1028-1030

10.1002/ca.22270 | PMID 23716143 Get It

Although the ulnar nerve is closely associated with the triceps brachii muscle, the literature does not normally describe it as supplying this muscle. However, recent research has examined the ulnar nerve in the upper arm and identified branches supplying the medial head of the triceps brachii muscle. This study aims to expand upon this research by describing the course and incidence of these branches in a larger sample size. We examined 50 specimens in 25 cadavers. Ulnar innervation of the medial head of the triceps brachii was identified in 14 specimens (28%). The mean distance of the ulnar nerve branch midpoint was 26% along a line between the surgical neck and an epicondyle line, with a range of 11–39%. Innervation of the triceps brachii muscle by the ulnar nerve has important clinical and surgical implications. Clin. Anat. 26:1028–1030, 2013. © 2013 Wiley Periodicals, Inc.
Risk Stratification of Patients with Extraprostatic Extension and Negative Lymph Nodes at Radical Prostatectomy: Identifying Optimal Candidates for Adjuvant Therapy
Eisenberg, Manuel S., Karnes, R. Jeffrey , Kaushik, Dharam , Rangel, Laureano J. , Bergstralh, Eric J., Boorjian, Stephen A.

Journal of Urology | May 29, 2013 | Volume: 190 | Issue: 5 | Pages: 1735-1741

10.1016/j.juro.2013.05.053 | PMID 23727312 Get It

The assessment of vascular risk in men with erectile dysfunction: the role of the cardiologist and general physician
Jackson, Graham, Miner, Martin , Billups, Kevin L., Carson, C C, Cunningham, Glenn R. , Hackett, Geoffrey , Kostis, J., Montorsi, P., Ramsey, M., Rosen, R., Sadovsky, Richard, Seftel, A D, Shabsigh, Ridwan, Wu, F.C.W., Nehra, Ashima , Burnett, Arthur L. “Bud” , Buvat, Irène , Goldstein, Irwin , Guay, Alexandre , Kloner, Robert A. , Vlachopoulos, Charalambos V.

International Journal of Clinical Practice | May 29, 2013 | Volume: 67 | Issue: 11 | Pages: 1163-1172

10.1111/ijcp.12200 | PMID 23714173 Get It

Bizarre Stromal Cells in the Esophagus
Dhungel, Bal M. , Petris, Giovanni De

International Journal of Surgical Pathology | May 29, 2013 | Volume: 21 | Issue: 4 | Pages: 368-372

10.1177/1066896913489347 | PMID 23714685 Get It

A significant mimicker of malignancy in the esophagus is the presence of atypical/bizarre stromal cells (BSCs). Two patients, a 60-year-old woman and a 59-year-old man, with esophageal polyps at the gastroesophageal junction showed highly atypical/bizarre cells in the polyps’ stroma. BSCs were admixed with inflammatory cells and had large atypical nuclei, prominent nucleoli, and variably abundant amphophilic cytoplasm. Immunohistochemical studies showed that BSCs expressed vimentin whereas S-100, CD68, HMB45, CD45, Pan-cytokeratin, CK5/6, p63, CD10, EMA, MART-1, desmin, smooth muscle actin, CD31, CD34, and CMV were negative. Ki-67 showed low proliferative rate (less than 1% positivity). No evidence of intracellular mucin was found after histochemical stains (AB/PAS and mucicarmine). Follow-up endoscopic mucosal resection was available in both cases and showed benign esophageal mucosa and submucosa with disappearance, in one case, or marked decrease of BSCs. Esophageal BSCs reports in the literature invariably locate them in distal esophagus polyps or masses. Awareness of BSCs, of their location and associations, may help to prevent misdiagnosis of malignancy. The literature of esophageal BSCs is reviewed and the approach to this abnormality is discussed.
Localized Tongue Amyloidosis: A Single Institutional Case Series
O’Reilly, Ashley G., D’Souza, Anita , Lust, John A., Price, Daniel L. , O'Reilly, Ashley, Price, Daniel L , D'Souza, Anita

Otolaryngology–Head and Neck Surgery | May 29, 2013 | Volume: 149 | Issue: 2 | Pages: 240-244

10.1177/0194599813490896 | PMID 23715681 Get It

ObjectiveReview Mayo Clinic experience of localized tongue amyloidosis.Study DesignCase series with retrospective chart review.SettingAcademic medical center.Subjects and MethodsCases of localized tongue amyloidosis were identified from the dysproteinemia database at the Mayo Clinic in Rochester, Minnesota. Electronic records were reviewed with focus on presenting symptoms, laboratory results (ie, serum or urine immunoelectrophoresis, bone marrow biopsy, and fat aspirate analysis), treatment modality, and status of disease at follow‐up.ResultsSix cases of localized tongue amyloidosis presented to the Mayo Clinic between 1969 and 2011. Mean patient age was 69 years (range, 43‐90). Patients presented with asymptomatic tongue mass(es). Biopsy of the tongue mass in all patients showed amyloid on Congo red stains. Work‐up for systemic amyloidosis, including bone marrow biopsy, fat aspiration, and serum and urine protein immunoelectrophoresis, was negative for all 6 patients, nor was there other organ involvement. Two patients underwent resection of the lesions, and the remaining patients elected for observation. Recurrence requiring repeat excision occurred in 1 of the patients that underwent resection. Repeat evaluation for systemic involvement was performed in 3 patients 1 to 3 years after the initial diagnosis. None of these patients went on to develop systemic involvement.ConclusionsLocalized tongue amyloidosis remains a rare diagnosis and requires exclusion of systemic involvement. Localized lesions may be observed or resected; however, recurrence may occur with resection. Patients with localized tongue amyloidosis do not appear to be at increased risk of developing systemic involvement.